BACKGROUND: Treatment guidelines for patients with moderate persistent asthma recommend regular therapy with a combination of an inhaled corticosteroid and a longacting \u3b22 agonist plus as-needed rapid-acting bronchodilators. We investigated whether symptom-driven budesonide and formoterol combination therapy administered as needed would be as effective as regular treatment with this combination plus as-needed symptom-driven terbutaline for patients with moderate asthma. METHODS: In this non-inferiority randomised clinical trial, we recruited adult patients (18-65 years of age) with stable moderate persistent asthma, according to 2006 Global Initiative for Asthma guidelines. Patients were recruited from outpatient clinics of secondary ...
Background: In many patients with mild asthma, the low frequency of symptoms and the episodic nature...
SummaryPurposeThe aim of this study was to demonstrate the equivalent efficacy of inhaled formoterol...
BACKGROUNDIn double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed bas...
BACKGROUND: Treatment guidelines for patients with moderate persistent asthma recommend regular the...
Background: Treatment guidelines for patients with moderate persistent asthma recommend regular ther...
Treatment guidelines for patients with moderate persistent asthma recommend regular therapy with a c...
Background: To evaluate efficacy and safety of a fixed dose combination of budesonide/formoterol inh...
OBJECTIVE: To study the effectiveness and safety of budesonide/formoterol (Symbicort) Maintenance An...
SummaryBudesonide/formoterol maintenance and reliever therapy (Symbicort SMART®) reduces asthma exac...
Budesonide/formoterol maintenance and reliever therapy (Symbicort SMART) reduces asthma exacerbation...
Background: In many patients with mild asthma, the low frequency of symptoms and the episodic nature...
SummaryBackgroundThe combination of inhaled corticosteroids and long-acting inhaled β2-adrenergic-ag...
Objectives:This study evaluated the efficacy and safety of a novel asthma management strategy - bude...
Background: In many patients with mild asthma, the low frequency of symptoms and the episodic nature...
SummaryPurposeThe aim of this study was to demonstrate the equivalent efficacy of inhaled formoterol...
BACKGROUNDIn double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed bas...
BACKGROUND: Treatment guidelines for patients with moderate persistent asthma recommend regular the...
Background: Treatment guidelines for patients with moderate persistent asthma recommend regular ther...
Treatment guidelines for patients with moderate persistent asthma recommend regular therapy with a c...
Background: To evaluate efficacy and safety of a fixed dose combination of budesonide/formoterol inh...
OBJECTIVE: To study the effectiveness and safety of budesonide/formoterol (Symbicort) Maintenance An...
SummaryBudesonide/formoterol maintenance and reliever therapy (Symbicort SMART®) reduces asthma exac...
Budesonide/formoterol maintenance and reliever therapy (Symbicort SMART) reduces asthma exacerbation...
Background: In many patients with mild asthma, the low frequency of symptoms and the episodic nature...
SummaryBackgroundThe combination of inhaled corticosteroids and long-acting inhaled β2-adrenergic-ag...
Objectives:This study evaluated the efficacy and safety of a novel asthma management strategy - bude...
Background: In many patients with mild asthma, the low frequency of symptoms and the episodic nature...
SummaryPurposeThe aim of this study was to demonstrate the equivalent efficacy of inhaled formoterol...
BACKGROUNDIn double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed bas...